approved EB-2 (NIW)

Postdoctoral Fellow Research Associate

Cancer Biology · Vietnam · 2023-05-26

Processing Time
103 days
Decision Date
2023-05-26
Location
Pennsylvania
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to introduce, evaluate, and refine innovative precision therapies to improve the treatment of leukemia and other blood cancers. This work focuses on developing targeted medical interventions to enhance clinical outcomes for patients with hematologic malignancies.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research into precision therapies for leukemia was found to have significant merit and importance to national health.

2 Well-positioned to Advance the Endeavor Met

The petitioner's academic background, publication record of 12 articles, and 210 citations demonstrate he is well-positioned.

3 Waiver of Job Offer and Labor Certification Met

On balance, the petitioner's contributions to cancer biology justify a waiver of the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in biological sciences, 12 peer-reviewed journal articles, and 210 citations. The case demonstrated that all three Dhanasar prongs were met, supported by a record of 8 peer-review assignments and funding from the European Union’s Horizon 2020 program.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Judging Experience
Original Contributions

Similar Cases

Assistant Professor

Healthcare · China

WeGreened EB-2 (NIW) approved
Pennsylvania 40 days 2025-05-13
The petitioner proposes to enhance CAR-T cell therapy for hematological malignancies by integrating laboratory research with patient-centered clinical trials. The work focuses on closing the translational gap to bring immunotherapy discoveries into clinical practice for leukemia and other blood cancers. The goal is to develop therapies that are more precise, responsive, and accessible to patients.

Doctor

Healthcare · India

WeGreened EB-2 (NIW) approved
New York 341 days 2025-05-23
The petitioner proposes to conduct high-quality clinical trials and literature reviews to discover new therapeutics and refine treatment protocols for hematologic malignancies and solid organ cancers. Her work focuses on enrolling patients in trials and synthesizing data on modern treatment approaches to improve care outcomes for patients with serious oncological conditions.

Research Fellow

Biotechnology · India

WeGreened EB-2 (NIW) approved
Massachusetts 111 days 2023-03-23
The petitioner proposes to continue her research in biomedical sciences, specifically optimizing therapeutic strategies for acute myeloid leukemia by elucidating molecular mechanisms. Her work focuses on identifying leukemia stem cell markers and critical transcription factors to develop advanced treatment strategies for therapy-resistant quiescent stem cells in blood cancer.

Scientist

Healthcare · Bangladesh

WeGreened EB-2 (NIW) approved
Japan 126 days 2022-04-15
The petitioner proposes to continue her research on investigating the pathways that regulate healthy and cancerous cells. This work aims to develop new therapeutic drugs and organ transplant technologies, specifically focusing on identifying genetic markers associated with cancerous cell growth and proliferation.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-05-26.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 103 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist